Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:FAICAR)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004389 AN007332 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Feces Pig Environmental stress North Carolina State University LC-MS
ST004389 AN007332 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Milk Pig Environmental stress North Carolina State University LC-MS
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Human Cancer Universitätsspital Zürich MALDI-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Mouse Cancer Universitätsspital Zürich MALDI-MS
ST003639 AN005977 Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells Cultured cells Human Cancer Portuguese Oncology Institute of Porto (IPO-Porto) LC-MS
ST003458 AN005682 Metabolomics of mice kidney to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part4 mice kidney metabolite) Kidney Mouse Sepsis Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Blood Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Brain Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Heart Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Liver Mouse Cancer Wistar Institute LC-MS
ST003435 AN005643 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media Zebrafish Cancer Wistar Institute LC-MS
ST003434 AN005641 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Mouse Cancer Wistar Institute LC-MS
ST003433 AN005639 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST002709 AN004391 FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer Cultured cells Human Cancer University of California, Los Angeles LC-MS
ST001954 AN003179 A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia Yeast cells Saccharomyces cerevisiae Friedreichs Ataxia University of California, Los Angeles LC-MS
ST001610 AN002644 Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours Lung Human Cancer Ohio University LC-MS
  logo